Physician profile
Giuseppe D'Amico
NPI 1124536016
$11,539.60
in general payments reported to CMS, 2019-2025
6 companies · $12K in 2025
The $12K reported for 2025 was more than what 92% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $2,844 · Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $2,843.91 |
| Food and Beverage | $195.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,068.40 | 2025 | |
| Transmedics, INC. | $1,275.51 | 2025 | Organ Care System |
| Madrigal Pharmaceuticals | $126.16 | 2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $24.88 | 2025 | Livtencity |
| Teleflex LLC | $24.63 | 2025 | Quikclot |
| Merck Sharp & Dohme LLC | $20.02 | 2025 | Prevymis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giuseppe D'Amico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.